The Gothenburg breast screening trial : First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization (pages 2091–2099)Nils Bjurstam, Lena Björneld, Stephen W. Duffy, Teresa C. Smith, Erling Cahlin, Olof Eriksson, Lars-Olof Hafström, Halvard Lingaas, Jan Mattsson, Stellan Persson, Carl-Magnus Rudenstam and Johan Säve-Söderbergh
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO;2-#
A randomized trial of mammographic screening for breast carcinoma was conducted in Gothenburg, Sweden among women ages 39-49 years, with an 18-month interscreening interval. A statistically significant 45% reduction in breast carcinoma mortality was observed in association with invitation to screening.